US FDA expands use of Bristol's cell therapy to treat rare blood cancer indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Bristol Myers Squibb (BMS) has entered into an agreement with Cellares to bolster the manufacturing of chimeric antigen receptor (CAR) T cell therapies.
BMS inks CAR T cell manufacturing deal with Cellares europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
Cellares, BMS announce $380M cell therapy manufacturing agreement njbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbiz.com Daily Mail and Mail on Sunday newspapers.